ALTEROLA BIOTECH INC. financial data

Symbol
ABTI on OTC
Location
Birkenhead Merseyside, United Kingdom
Fiscal year end
31 March
Latest financial report
10-Q - Q3 2024 - 29 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21% % 182%
Quick Ratio 0.05% % 0%
Debt-to-equity -143% % -542%
Return On Equity 213% %
Return On Assets -555% % 49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,459,502,018 shares
Common Stock, Shares, Outstanding 1,467,475,449 shares 89%
Common Stock, Value, Issued $1,467,485 USD 89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $64,869 USD
General and Administrative Expense $24,023 USD 1.6%
Operating Income (Loss) $2,560,014 USD -76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $654,747 USD -46%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $3,258,125 USD -124%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $82,720 USD
Inventory, Net $1,069 USD 9.6%
Assets, Current $1,147,024 USD 482%
Assets $1,364,069 USD 174%
Accounts Payable, Current $805,308 USD 12%
Accrued Liabilities, Current $461,989 USD 88%
Liabilities, Current $3,615,314 USD 44%
Liabilities $3,615,314 USD 44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $35,629 USD
Retained Earnings (Accumulated Deficit) $13,673,734 USD -31%
Stockholders' Equity Attributable to Parent $2,054,964 USD -1.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,251,245 USD -8.2%
Liabilities and Equity $1,364,069 USD 174%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $207,163 USD -167%
Net Cash Provided by (Used in) Financing Activities $923,003 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 1,467,475,449 shares 89%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $715,840 USD 579%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $82,720 USD 809%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,190,566 USD -438%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $10,226,499 USD 35%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $337,297 USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%